Migraine Drugs Market Size - Forecasts to 2026
Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Global Migraine Drugs Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/global-migraine-drugs-market-3116
By Treatment (Acute or Abortive [Triptans, Ergot, Alkaloids, and Others] and Preventive or Prophylactic [Botulinum Toxin, Topiramate, and Others]), By Route of Administration (Oral, Injection, and Others), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); Company Market Share Analysis, End-User Landscape, and Competitor Analysis.
Key Market Insights
• The increased emphasis on drug discovery is foreseen to aid in the market growth of migraine drug market participants.
• Acute or abortive treatments hold a significant share in this market because they are available in different shapes and formulations.
• The oral route of administration held a significant share in this market because it can boost efficacy and patient adherence by eliminating migraine cycle continuation.
• North America has been presumed to lead the global market due to the increasing proliferation of migraines.
• Allergan Plc, Alder Biopharmaceuticals, Inc., Pfizer Inc., GlaxoSmithKline Plc, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca Plc, Johnson & Johnson, Amgen Inc., Eli Lilly and Company, eNeura Inc., amongst others, are the major players in the migraine drugs market.
Browse the Report @ https://www.globalmarketestimates.com/market-report/global-migraine-drugs-market-3116
Treatment Type Outlook (Revenue, USD Billion, 2021-2026)
• Acute or Abortive
• Preventive or Prophylactic
• Botulinum Toxin
Route of Administration Outlook (Revenue, USD Billion, 2021-2026)
Regional Outlook (Revenue, USD Billion, 2021-2026)
• The U.S.
• Rest of Europe
• South Korea
• Rest of APAC
Central & South America
• Rest of CSA
Middle East & Africa
• Saudi Arabia
• Rest of MEA
Contact: Yash Jain
Email address: email@example.com
Phone Number: +16026667238
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php
B-502, Kemp Plaza, Mindspace, Malad West, Mumbai: 400 064, India
Global Market Estimates is an India based market research and consulting company. The company provides syndicated research reports, customised research reports and consulting services to their clients and helps them achieve their business goals on a commercial level. Global Market Estimates database is used by the world's well known and prolific academic institutions and Fortune 500 companies to understand the global and regional business environment to excel in their business goals.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Migraine Drugs Market Size - Forecasts to 2026 here
News-ID: 2284897 • Views: 341
More Releases from Global Market Estimates Research & Consultants
Fuel Cell Buses Market Size - Forecast to 2026
As per the research conducted by GME, the Fuel Cell Buses Market will grow with a CAGR value of around 25 percent over the forecast period. Browse TOC on “Global Fuel Cell Buses Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/global-fuel-cell-buses-market-3281 By Component (Fuel Stack, Fuel Processor, Power Conditioner, Air Compressor, Humidifier), By Power Output (Upto 400 KWH, Above 400 KWH), By Deployment (Battery Dominant, On Route Charge, Plug-in Charge), By Region (North
Global Patient Recovery Chair Market- Forecast to 2026
The findings reviewed by GME stated that the Global Patient Recovery Chair Market is estimated to be valued at USD 6100 million in 2021 and is projected to reach USD 8750 million by 2026 at a CAGR of 7.5 %. Advancements in technology and the production of improved electric recovery chairs that are transportable and can be used in home care environments are likely to support the advancement of the
Global Intraoperative Imaging Market- Forecast to 2026
The findings reviewed by GME stated that the Global Intraoperative Imaging Market is estimated to be valued at USD 1900 million in 2021 and is projected to reach USD 2500 million by 2026 at a CAGR of 5%. A few of the important drivers propelling the advancement of the intraoperative imaging market include technological developments, growing surgical frequency, and improved financing and public-private partnerships. Browse 159 Market Data Tables and 119
Global Industrial Display Market – Forecasts to 2026
As per the research conducted by GME, the Global Industrial Display Market will grow with a CAGR value of 6.4 percent. Factors like the development of high specification devices, improved contrast ratio, high growth of LED-backlit, wide temperature range, new product developments are foreseen to result in the growth of the industrial display market. Browse 159 Market Data Tables and 119 Figures spread through 189 Pages and in-depth TOC on
More Releases for Migraine
Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025
Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea and even altered vision in some cases. The increase in the prevalence of migraine, the rapid increase in the female population and the increased awareness among patients for the treatment and prevention of migraine are driving the growth of the global market for anti-migraine drugs. Get Access to TOC /
EpiCast Report: Migraine-Epidemiology Forecast to 2026
Migraine is characterized by recurring headaches and throbbing pain on one side of the head accompanied by nausea, vomiting, or increased sensitivity to light or smell. While most migraineurs experience episodic migraines (EM), a small percentage suffers from chronic migraine (CM). In addition to its debilitating pain, migraines are also associated with more severe cardiovascular and neuropsychological comorbidities. Because migraine is one of the most prevalent types of headache, there
Migraine Therapeutics Pipeline Analysis -Results, Designation, Collaboration
Migraine is a type of a severe headache that is characterized by the intense throbbing in one area of the head. According to National Institute of Neurological Disorders and Stroke, migraine is three times common in women than in men and it is heralded by visual disturbances such as zig-zag lines vision and flashing lights. Access Report Overview: https://www.psmarketresearch.com/market-analysis/migraine-therapeutics-pipeline-analysis People having migraine generally have frequent attacks that cause, anxiety, stress,
Migraine KOL Interview
ReportsWorldwide has announced the addition of a new report title Migraine KOL Interview to its growing collection of premium market research reports. For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/biosimilar-insulin-market-access February 08, 2017 We interviewed a neurologist based in the US who specializes in headache medicine to gauge his current and anticipated future use of acute and prophylactic agents in the treatment of episodic
Migraine Disease Coverage Forecast and Market Analysis
ReportsWorldwide has announced the addition of a new report title Migraine Disease Coverage Forecast and Market Analysis to its growing collection of premium market research reports. For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/migraine-disease-coverage-forecast-and-market-analysis Introduction Migraine is a common, disabling, and recurring neurological disorder characterized by severe headache co-occurring with nausea, vomiting, and other symptoms, the duration of which can range from hours to days.
Global Migraine Market: Industry Analysis & Outlook 2021
Migraine is a chronic neurovascular disorder characterized by severe recurrent headaches. It is one of the most common and most prevalent disabling neurological conditions, characterized by episodes often called migraine attacks. They are quite different from regular headaches which are non-migrainous. Migraineurs generally have a lower threshold to triggers that might cause neuronal hyperexcitability, including sleep disturbances, environmental or emotional challenges, alcohol exposure, diet, and hormonal cycles/changes, among others. Migraine